Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials.
暂无分享,去创建一个
D. Klonoff | J. Buse | D. Maggs | L. L. Nielsen | X. Guan | C. Bowlus | J. Holcombe | M. Wintle